Citigroup Inc. Begins Coverage on Intercontinental Exchange Inc. (ICE)

TAC's SI was 647,900 shares in July as released by FINRA. Janney Montgomery Scott Limited Liability Corp has 87,568 shares. With 489,900 avg volume, 10 days are for Ultragenyx Pharmaceutical Incorporated (NASDAQ:RARE)'s short sellers to cover RARE's short positions. Groesbeck Mngmt Corporation Nj holds 0.62% or 14,070 shares. About 957,618 shares traded. Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) has declined 6.49% since July 17, 2016 and is downtrending. It has underperformed by 4.22% the S&P500.

More notable recent First Republic Bank (NYSE:FRC) news were published by: which released: "Analyst Actions: BMO Capital Trims First Republic Bank PT to $96 Following Q2 ..." on July 17, 2017, also with their article: "First Republic Bank Releases Results of 2017 Dodd-Frank Act Company-Run ..." published on June 22, 2017, published: "First Republic Bank Announces Second Quarter 2017 Earnings and Conference Call ..." on June 28, 2017. Therefore 53% are positive. Intercontinental Exchange has $314 highest and $60 lowest target.

The stock is trading at $65.55 which is slightly above $62.12, the 50 day moving average and barely above the 200 day moving average of $59.66.

On July 13 the company was changed to a "Sector Outperform" in a report from RBC Capital up from the previous "Buy" rating. Intercontinental Exchange Inc (NYSE:ICE) has risen 13.80% since July 17, 2016 and is uptrending. Wood maintained the stock with "Buy" rating in Friday, March 24 report. The firm has "Buy" rating by Deutsche Bank given on Friday, January 8. On Friday, March 10 the stock rating was maintained by RBC Capital Markets with "Sector Perform". The firm earned "Buy" rating on Tuesday, December 13 by Needham. Intercontinental Exchange Inc (NYSE:ICE) has risen 13.80% since July 18, 2016 and is uptrending. The business's revenue was up.9% compared to the same quarter previous year. Standpoint Research has "Hold" rating and $257 target. The company was maintained on Friday, July 14 by BMO Capital Markets.

Several equities research analysts have recently commented on ICE shares. Dubuque Bancorp invested 0% in Intercontinental Exchange Inc (NYSE:ICE).

Among 15 analysts covering Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), 10 have Buy rating, 1 Sell and 4 Hold. Barclays analysts stated on 09/08/2016 that they maintained their Overweight rating.

COPYRIGHT VIOLATION NOTICE: "Citigroup Inc". The stock has "Outperform" rating by Wood on Friday, April 8. The firm earned "Hold" rating on Thursday, April 6 by Jefferies. The stock rose 0.75% or $0.49 reaching $66.04 per share. Credit Suisse initiated Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) on Thursday, January 21 with "Outperform" rating. Its down 0.14, from 1.21 in 2016Q3.

Central Trust Co reduced its position by selling 4,353 shares a decrease of 98.6%. 127 funds opened positions while 452 raised stakes. Ep Wealth Inc holds 40,909 shares. State Of Alaska Department Of Revenue owns 58,035 shares for 0.3% of their portfolio. 379,761 were reported by Rockefeller Financial. Capital Ww Invsts holds 0% or 256,000 shares in its portfolio. Wexford Capital LP invested 0.07% of its portfolio in Mueller Industries, Inc. Us Bancorporation De has 1,463 shares. Manufacturers Life Ins Company The holds 0.09% or 1.12 million shares. Moreover, Raymond James And Associates has 0% invested in Ultragenyx Pharmaceutical Inc (NASDAQ:RARE). Cubist Systematic Strategies Lc reported 6,280 shares stake. The New York-based Rothschild Asset Management has invested 0.03% in Ultragenyx Pharmaceutical Inc (NASDAQ:RARE). Dalton Greiner Hartman Maher reported 511,833 shares or 1.19% of all its holdings. 3,507 are owned by Citadel Ltd Liability Corporation.

Achaogen, a late-stage biopharmaceutical company. Efg Asset Management Americas Corp who had been investing in Intercontinental Exchange In for a number of months, seems to be bullish on the $39.08 billion market cap company. The Firm is engaged in the discovery, development and commercialization of antibacterial treatments against multi-drug resistant gram-negative infections. It now has negative earnings.

Investors sentiment increased to 11.77 in 2016 Q4. Its up 10.76, from 1.01 in 2016Q3. It is positive, as 32 investors sold ICE shares while 16 reduced holdings. 77 funds opened positions while 488 raised stakes. The stock declined 0.39% or $0.12 reaching $30.97 per share. Wall Street Access Asset Mngmt Limited Liability owns 50,515 shares for 1.58% of their portfolio. Ballentine Ptnrs Ltd Liability holds 0.02% or 19,823 shares. 785,716 were accumulated by Sei Investments. Oakwood Capital Management Ltd Limited Liability Company Ca invested in 1.24% or 85,985 shares. Endeavour Cap Advsr Inc owns 872,946 shares for 3.08% of their portfolio. Korea Invest Corporation holds 0.29% of its portfolio in Intercontinental Exchange Inc (NYSE:ICE) for 1.08 million shares. The stock has a market cap of $7.56 billion, a price-to-earnings ratio of 25.38 and a beta of 0.71.

Shares of Intercontinental Exchange (ICE) traded up 0.41% on Wednesday, hitting $65.82. Officer reported the sale of 15,000 shares. Amalgamated National Bank & Trust has invested 0.13% in Intercontinental Exchange Inc (NYSE:ICE). Ledyard Fincl Bank holds 0.82% or 81,959 shares in its portfolio.

Latest News